Recent Finacing
Recent Raise
Tenaya Therapeutics develops AAV-based gene therapies and in vivo cellular reprogramming for cardiomyopathies, uses iPSC-derived cardiomyocyte disease models, and operates in-house AAV capsid engineering and manufacturing.
